Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/24 16:11 | 5/21/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Cislini Jeff | CA | O | GC | 3 | S | -145 | 34.03 | 0 | -4 | 56 | D | |||||||||||||||
5/3/24 19:36 | 5/3/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Anders Jack | CA | O | CFO | 2 | S.d | -440 | 39.08 | 0 | -11 | 102 | D | |||||||||||||||
4/12/24 20:08 | 4/10/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Goldsmith Mark A | CA | DO | See Rema | 2 | S | -802 | 34.45 | 0 | -23 | 859 | M | |||||||||||||||
4/12/24 16:23 | 4/10/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | CA | D | 1 | S.d | -80 | 37.00 | 0 | -2 | 16 | D | ||||||||||||||||
3/20/24 16:45 | 3/18/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Kelsey Stephen Michael | CA | O | See Rema | 1 | S | -67 | 31.58 | 0 | -2 | 271 | D | |||||||||||||||
3/20/24 16:44 | 3/18/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Horn Margaret A | CA | O | COO | 2 | S.dm | -898 | 33.77 | 0 | -27 | 142 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |